FAP and Patent ductus arteriosus: showed that production of chemokine (C-X-C motif) ligand 12 (CXCL12) by FAP+CAFs mediates the immune suppressive activity and accounts for the failure of T cell checkpoint inhibitors in pancreatic ductal adenocarcinoma (PDA) (39).